Who owns Genes?

Key details on Genes (Ticker: GCO)

Who owns Genes?

Is GCO a good stock to own? Find out who bought Genes, who sold Genes (GCO) stock, and who holds a large position in Genes.

Fund Name Number of Shares Share Valuation As Of
FMR 3.68M $275.08M Sept. 30, 2014
Damian Sousa 2.88M $220.66M Dec. 31, 2014
Royce & Associates 2.02M $155.06M Dec. 31, 2014
Vanguard 1.55M $118.54M Dec. 31, 2014
BlackRock Fund Advisors 1.35M $103.78M Dec. 31, 2014
Franklin Resources 1.27M $97.36M Dec. 31, 2014
Charles Schwab Bank 818666 $13.62M March 31, 2013
STATE STREET CORPORATION 713787 $54.70M Dec. 31, 2014
DIMENSIONAL FUND ADVISORS 713507 $54.67M Dec. 31, 2014
LORD, ABBETT & CO 643787 $49.33M Dec. 31, 2014
CHILTON INVESTMENT 632377 $41.47M Sept. 30, 2013
Vinik Asset Management 603889 $36.32M June 30, 2012
BlackRock Institutional Trust Company, N.A. 593832 $45.50M Dec. 31, 2014
Pembroke Management 578500 $42.27M Dec. 31, 2013
Cambiar Investors 572748 $43.88M Dec. 31, 2014
Buckingham Capital Management 561826 $37.49M Sept. 30, 2012
Columbus Circle Investors 537205 $35.85M Sept. 30, 2012
LOMBARDIA CAPITAL PARTNERS 526479 $40.34M Dec. 31, 2014
Ranger Investment Management 521640 $34.81M Sept. 30, 2012
OppenheimerFunds 501566 $27.59M Dec. 31, 2012
Rainier Investment Management 500830 $33.42M Sept. 30, 2012
Integrity Asset Management 458139 $17.18M Dec. 31, 2010
Inves 452496 $30.20M Sept. 30, 2012
FRIESS ASSOCIATES 451500 $32.35M March 31, 2012
GOLDMAN SACHS 439747 $29.34M Sept. 30, 2012
Macquarie 422389 $34.69M June 30, 2014
BlackRock Advisors 420259 $27.56M Sept. 30, 2013

Who sold Genes?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 597623 $31.14M
Ameriprise Financial June 30, 2011 542485 $28.26M
Wells Fargo & Company March 31, 2011 1.11M $44.33M
Norges Bank Investment Management March 31, 2011 676347 $27.19M
Manufacturers Life Insurance Company Dec. 31, 2002 555028 $17.27M